帕金通过调节PD-1/PD-L1信号传递来调节肝细胞癌微环境
Guiqin Ye1, Xin Sun2, Jiuzhou Li3
1Clinical Laboratory, The Yuhuan People's Hospital, Taizhou 317600, China; Cancer Center, Department of Medical Oncology, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
Journal of advanced research
|January 4, 2025
概括
帕金素缺乏症通过降低线粒和增加PD-1表达来降低肝癌免疫力. 恢复帕金细胞或线粒细胞功能可能会增强抗瘤反应和HCC的免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 帕金介导的线粒对于清除受损的线粒体和抑制瘤发展至关重要.
- 人们越来越多地认识到线粒细胞在瘤免疫力中的作用,但机制仍然不清楚.
研究的目的:
- 为了研究帕金在四化碳诱导的肝脏瘤的免疫微环境中的作用.
- 阐明帕金通过PD-1表达影响瘤免疫力的机制.
主要方法:
- 单细胞RNA测序T淋巴细胞和骨髓细胞衍生的细胞.
- 西部斑点,免疫光和共免疫沉.
- 定量蛋白质组分析.
主要成果:
- 在小鼠中,帕金缺乏症 (Park2-/-) 导致严重的肝损伤,恶性瘤增加和免疫抑制瘤微环境.
- 在Park2-/-小鼠中观察到细胞毒性CD8+ T细胞的减少和CD8+ T细胞耗尽的增加 (PD-1+,Lag3+,Tigit+).
- 在帕金氏缺陷肝脏中发现了与PD-1和抗原呈现途径相关的M2类巨细胞和差异性蛋白质表达的增加.
- 帕金素缺乏症降低了肝细胞,通过创造一种免疫抑制的微环境,促进肝癌.
结论:
- 帕金是一种E3泛素酶,在肝癌中降解PD-1,通过PD-1/PD-L1通路影响抗瘤免疫力.
- 重新引入帕金素或增强线粒可以重塑瘤微环境,激活抗瘤免疫力.
- 准帕金或线性瘤是一种有前途的策略,可以提高肝细胞癌 (HCC) 免疫疗法的疗效.
相关概念视频
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K


